Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Qun Zhou

Showing results (61-70 of 114) with videos related to

Pageof 12
Sort By:
AI Zheng = Aizheng = Chinese Journal of Cancer|January 16, 2003
[Correlation and significance of E-cadherin and N-cadherin expression in prostate cancer]Xiao Huang, Li-qun Zhou, Jun-kui Ai, et al.
Zhonghua Yi Xue Za Zhi|October 27, 2006
[Expression of nucleosomal binding protein 1 in normal prostate benign prostate hyperplasia, and prostate cancer and significance thereof]Gang Song, Li-qun Zhou, Mai Weng, et al.
The Kaohsiung Journal of Medical Sciences|September 4, 2018
The significance of the initial symptom in Chinese patients with upper tract urothelial carcinoma: Regular health examination is still underutilizedDong Fang, Yan-Qing Gong, Nirmish Singla, et al.
Zhonghua Yi Xue Za Zhi|July 21, 2005
[Association between A49T polymorphism of SRD5A2 gene and risk of prostate cancer]Ming Tong, Jun-kui Ai, Yi-ming Yuan, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|April 28, 2005
[Short-term neoadjuvant hormone therapy enhanced expression of clusterin in prostate cancer]Yi-nong Niu, Dian-qi Xin, Zhi-song He, et al.
American Journal of Cancer Research|January 13, 2025
NRP1 overexpression potentially enhances osimertinib resistance in NSCLC via activation of the PI3K/AKT signaling pathwayYi Wang, Bao-Lan Wang, Li-Qun Zhou, et al.
Cancer Management and Research|June 14, 2019
Short-term benefit of neoadjuvant hormone therapy in patients with localized high-risk or limited progressive prostate cancerBing-Lei Ma, Lin Yao, Yu Fan, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|April 28, 2006
[Prediction of the stage of patients with prostate cancer by the combination of serum prostate specific antigen and Gleason score]Gang Song, Li-qun Zhou, Zhi-song He, et al.
World Journal of Urology|October 15, 2013
Prevalence of baseline chronic kidney disease in 2,769 Chinese patients with renal cancer: nephron-sparing treatment is still underutilizedKai-wei Yang, Geng-yan Xiong, Xue-song Li, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|August 19, 2014
[Technique of renal pedicle control in transperitoneal laparoscopic nephrectomy: experience of 191 cases by a single surgeon]Lei Zhang, Lin Yao, Xue-song Li, et al.
Pageof 12

Showing results (61-70 of 114) with videos related to

Sort By:
Pageof 12
AI Zheng = Aizheng = Chinese Journal of Cancer|January 16, 2003
[Correlation and significance of E-cadherin and N-cadherin expression in prostate cancer]Xiao Huang, Li-qun Zhou, Jun-kui Ai, et al.
Zhonghua Yi Xue Za Zhi|October 27, 2006
[Expression of nucleosomal binding protein 1 in normal prostate benign prostate hyperplasia, and prostate cancer and significance thereof]Gang Song, Li-qun Zhou, Mai Weng, et al.
The Kaohsiung Journal of Medical Sciences|September 4, 2018
The significance of the initial symptom in Chinese patients with upper tract urothelial carcinoma: Regular health examination is still underutilizedDong Fang, Yan-Qing Gong, Nirmish Singla, et al.
Zhonghua Yi Xue Za Zhi|July 21, 2005
[Association between A49T polymorphism of SRD5A2 gene and risk of prostate cancer]Ming Tong, Jun-kui Ai, Yi-ming Yuan, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|April 28, 2005
[Short-term neoadjuvant hormone therapy enhanced expression of clusterin in prostate cancer]Yi-nong Niu, Dian-qi Xin, Zhi-song He, et al.
American Journal of Cancer Research|January 13, 2025
NRP1 overexpression potentially enhances osimertinib resistance in NSCLC via activation of the PI3K/AKT signaling pathwayYi Wang, Bao-Lan Wang, Li-Qun Zhou, et al.
Cancer Management and Research|June 14, 2019
Short-term benefit of neoadjuvant hormone therapy in patients with localized high-risk or limited progressive prostate cancerBing-Lei Ma, Lin Yao, Yu Fan, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|April 28, 2006
[Prediction of the stage of patients with prostate cancer by the combination of serum prostate specific antigen and Gleason score]Gang Song, Li-qun Zhou, Zhi-song He, et al.
World Journal of Urology|October 15, 2013
Prevalence of baseline chronic kidney disease in 2,769 Chinese patients with renal cancer: nephron-sparing treatment is still underutilizedKai-wei Yang, Geng-yan Xiong, Xue-song Li, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|August 19, 2014
[Technique of renal pedicle control in transperitoneal laparoscopic nephrectomy: experience of 191 cases by a single surgeon]Lei Zhang, Lin Yao, Xue-song Li, et al.
Pageof 12